SCHEMBL4206436

SCHEMBL4206436

CC(C)(C)OC(=O)N(N)C(=O)Cc1cc(=O)oc2cc(O)ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.58
▸ ALDH1A1 P00352 4/20 0.58
▸ GAA P10253 3/20 0.58
▸ GLA P06280 3/20 0.58
▸ LCK P06239 2/20 0.56
▸ AKR1B1 P15121 2/20 0.56
▸ FYN P06241 1/20 0.56
▸ GRB2 P62993 1/20 0.56
▸ HSD17B3 P37058 10/20 0.53
▸ ERAP1 Q9NZ08 1/20 0.48
▸ LMNA P02545 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ POLB P06746 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4209954 0.83 BCHE (0.56) CYP3A4MAOB
SCHEMBL4211117 0.79 AKR1B1 (0.70) KDM4EALDH1A1GAAGLALCK
SCHEMBL4206438 0.78 ALDH1A1 (0.63) KDM4EALDH1A1GAAGLALCK
SCHEMBL10001918 0.75 ALDH1A1 (0.60) KDM4EALDH1A1GAAGLALCK
SCHEMBL4211454 0.75 ALDH1A1 (0.60) KDM4EALDH1A1GAAGLALCK
SCHEMBL20767985 0.75 ALDH1A1 (0.59) KDM4EALDH1A1GAAGLALCK
SCHEMBL13851560 0.75 ALDH1A1 (0.56) KDM4EALDH1A1GAAGLALCK
SCHEMBL723839 0.74 LCK (0.76) KDM4EALDH1A1GAAGLALCK
SCHEMBL13840541 0.74 AKR1B1 (0.76) KDM4EALDH1A1GAAGLALCK
SCHEMBL4209634 0.74 KDM4E (0.76) KDM4EALDH1A1GAAGLALCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090005436-A1 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives NEWRON PHARMACEUTICALS S.P.A. (IT) 2009-01-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005436-A1 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives MAOB, MAOA, AOC3 KDM4E 1607/4885ALDH1A1 368/4885GAA 1150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback